Overview
Kisspeptin-10 is classified as a reproductive peptide peptide. LH/FSH stimulation, testosterone support, fertility enhancement, HPG axis activation.
Endogenous neuropeptide that is the master upstream regulator of the hypothalamic-pituitary-gonadal (HPG) axis. Kisspeptin-10 binds to the GPR54 (KISS1R) receptor on GnRH neurons, triggering pulsatile GnRH release which stimulates LH and FSH secretion from the pituitary. This cascade drives testosterone production in males and ovulation in females. Unique advantage: activates the reproductive axis at its highest control point without bypassing natural feedback loops.
Also known as: KP-10, Metastin 45-54, KISS1
Category
Reproductive Peptide
Half-Life
0.5h
Route
SubQ
FDA Status
Not Approved
How Does Kisspeptin-10 Work?
Endogenous neuropeptide that is the master upstream regulator of the hypothalamic-pituitary-gonadal (HPG) axis. Kisspeptin-10 binds to the GPR54 (KISS1R) receptor on GnRH neurons, triggering pulsatile GnRH release which stimulates LH and FSH secretion from the pituitary. This cascade drives testosterone production in males and ovulation in females. Unique advantage: activates the reproductive axis at its highest control point without bypassing natural feedback loops.
At the molecular level, Kisspeptin-10 operates through pathways characteristic of the Reproductive Peptide class, interacting with target receptors and downstream signaling cascades to produce its observed effects.
Published Research
The following studies are indexed from PubMed and peer-reviewed journals:
[1]Kisspeptin potently stimulates LH and testosterone in healthy men
Dhillo et al. (J. Clin. Endocrinol. Metab.): IV Kisspeptin-10 (1mcg/kg) potently stimulates LH pulse frequency and testosterone secretion in healthy men, establishing its role as a reproductive axis activator.
Evidence: moderate[2]Kisspeptin restores LH pulsatility in hypogonadal men
George et al.: Kisspeptin-10 infusion restores LH pulsatility and increases testosterone in men with type 2 diabetes-associated hypogonadism, demonstrating therapeutic potential.
Evidence: moderate[3]Kisspeptin as alternative oocyte maturation trigger in IVF
Abbara et al. (J. Clin. Invest.): Kisspeptin-54 triggers oocyte maturation in women undergoing IVF with significantly lower risk of ovarian hyperstimulation syndrome (OHSS) vs. hCG trigger.
Evidence: strong[4]Kisspeptin stimulates reproductive hormones in women
Jayasena et al.: Kisspeptin-10 administration increases LH secretion in women, with response magnitude dependent on menstrual cycle phase (strongest in preovulatory phase).
Evidence: moderate[5]Kisspeptin tachyphylaxis with continuous administration
Ramaswamy et al.: Continuous Kisspeptin-10 infusion leads to desensitization of the HPG axis within 24-48 hours, indicating pulsatile dosing protocols are necessary for sustained efficacy.
Evidence: preclinical[6]Knockout of PI4-Kinase A in GnRH Neurons Causes their Prepubertal Death.
In a 2026 study on mice, researchers demonstrated that phosphatidylinositol 4-kinase alpha is essential for the postnatal survival of GnRH neurons, though not for their embryonic development. The study found that knocking out this enzyme caused prepubertal neuron death, resulting in infertility in both sexes.
Evidence: preclinical[7]Diagnostic Criteria and Genetic Basis of Polycystic Ovary Syndrome: A Narrative Review.
Polymorphisms in genes regulating insulin metabolism, steroidogenesis, and the hypothalamic-pituitary-ovarian axis were found to drive the clinical variability of Polycystic Ovary Syndrome. A 2026 review investigated these genetic markers to highlight their role in the disorder's pathophysiology.
Evidence: emerging[8]Spatial transcriptional mapping reveals the molecular characteristics of juxtaglomerular cell tumors.
High KISS1 expression and the PPARG, NOTCH, and PDGFB pathways were identified as key regulators of juxtaglomerular cell tumor development and renin secretion in a 2026 spatial transcriptomic analysis. The study demonstrated that REN expression positively correlates with KISS1 across multiple tumor types.
Evidence: emerging[9]Photoperiodic modulation of puberty through melatonin-kisspeptin-GnRH signalling in female Wistar rats.
A 2026 study in female Wistar rats demonstrated that photoperiod-dependent melatonin signaling and estradiol synergistically modulate hypothalamic gene networks crucial for pubertal regulation. Researchers found that long-day photoperiods advanced puberty, while melatonin suppressed Kiss1 and GnRH expression in vitro.
Evidence: preclinical[10]Expressions of Kisspeptin System and Ki-67 in the Reproductive Tissues of Cyclic Bitches.
A 2026 study in female dogs demonstrated that kisspeptin (KISS1) and Ki-67 expression significantly increased in the endometrium during estrus. These findings suggest that local kisspeptin signaling plays a coordinated role in endometrial proliferation and tissue remodeling during the reproductive cycle.
Evidence: preclinical[11]Kisspeptin-10 attenuates pulmonary arterial hypertension via restoration of mitochondrial function in pulmonary artery smooth muscle cells.
Kisspeptin-10 was found to attenuate pulmonary arterial hypertension and vascular remodeling in a mouse model by restoring mitochondrial homeostasis, according to a 2026 study. The peptide also demonstrated an ability to inhibit hypoxia-induced cell proliferation in vitro.
Evidence: preclinical[12]Relationship between kisspeptin-10, neurokinin B and dynorphin A in the course of normal and delayed puberty in ewes.
A 2026 study in ewes demonstrated that the initiation of ovarian activity is associated with concurrent increases in plasma kisspeptin-10 and neurokinin B concentrations, alongside reduced dynorphin A levels. These findings suggest these neuropeptides regulate the timing of reproductive onset.
Evidence: preclinical[13]Kisspeptin-10 Promotes Hormone Secretion, Ovarian Follicles Development and Fecundity via PI3K/AKT/ERK Signal Pathway in Mice.
A 2026 study demonstrated that Kisspeptin-10 promoted ovarian follicle development, enhanced hormone secretion, and increased follicular cell proliferation in mice. The peptide was found to suppress apoptosis and autophagy by activating the PI3K/AKT/ERK signaling pathway.
Evidence: preclinical[14]Serum kisspeptin levels in women with polycystic ovary syndrome: A systematic review and meta-analysis.
A 2026 meta-analysis demonstrated significantly higher serum kisspeptin levels in women with polycystic ovary syndrome compared to controls. Researchers found this elevation was most pronounced in overweight and obese patients, highlighting a potential interaction between metabolic status and reproductive neuroendocrine regulation.
Evidence: very strong[15]GABA receptor modulation of arcuate kisspeptin neuron bursting and synchronization activity in female mice.
A 2026 study in female mice demonstrated that sustained GABAergic input suppresses the burst firing and synchronization of arcuate kisspeptin neurons through both GABAA and GABAB receptors. These findings suggest GABAergic inputs can modulate the frequency of reproductive hormone pulse generator activity.
Evidence: preclinical[16]Effects of contraceptive (gestodene) on hatching, embryo development, and reproduction in Oryzias latipes.
A 2026 study found that gestodene reduced post-hatching survival, decreased egg production, and inhibited the spawning ability of female Japanese medaka. The contraceptive adversely affected overall reproduction without altering the expression of genes associated with female mating receptivity.
Evidence: preclinical[17]Idiopathic Hypogonadotropic Hypogonadism with a Rare Hemi-Arrhinia: A Case Report with Nasal Reconstruction.
A 2026 case report identified inherited missense mutations in the GNRHR and KISS1 genes in a patient with idiopathic hypogonadotropic hypogonadism and congenital hemi-arrhinia. The study demonstrated that a four-stage surgical reconstruction successfully improved aesthetic outcomes without altering nasal airflow.
Evidence: anecdotal[18]Cadmium-Induced Neuroendocrine Alterations: Gene Expression of the Kisspeptin-GnRH Axis and Delayed Puberty in Male Rats.
A 2026 study in male rats demonstrated that cadmium exposure delayed pubertal onset and reduced serum testosterone levels. The research found that this disruption was linked to decreased hypothalamic expression of Kiss1, Kiss1r, and Gnrh1 genes within the kisspeptin-GnRH axis.
Evidence: preclinical[19]Asprosin infusion modulates central circuits to rescue selective serotonin reuptake inhibitor-induced male dysfunction.
A 2026 study found that central infusion of the adipokine asprosin restored erectile function, copulatory behavior, and testicular morphology in rats treated with selective serotonin reuptake inhibitors. The research demonstrated that asprosin improved sperm concentration and motility while modulating central reproductive circuits.
Evidence: preclinical[20]Leptin Receptor b (LEPRb) Mutations Disrupt Hypothalamic Control of the Reproductive Axis.
A 2026 review found that LEPRb mutations disrupt hypothalamic circuitry upstream of GnRH neurons, impairing reproductive function and causing hypogonadotropic hypogonadism. The study investigated the central role of kisspeptin-mediated signaling in leptin-dependent reproductive regulation.
Evidence: emergingSafety Profile
Endogenous human neuropeptide with growing clinical trial data. Tachyphylaxis (desensitization) occurs with continuous dosing; pulsatile/intermittent protocols required. Being investigated as a safer IVF trigger (vs. hCG). Not FDA-approved for therapeutic use. Research-only.
| Side Effect | Incidence | Severity |
|---|---|---|
| Injection site reaction | ~8% of users | mild |
| Mild headache | ~5% of users | mild |
| Flushing / warmth | ~5% of users | mild |
| Tachyphylaxis (with continuous dosing) | Variable | moderate |
Sourcing Kisspeptin-10 for Research
If you're looking to source Kisspeptin-10 for laboratory research, our vendor directory compares pricing, purity testing, and COA verification from independently vetted suppliers.
* Research vendor — verify your regional regulations before purchase.
Full Research Profile
Kisspeptin-10 — dosing, interactions, timelines & more
Comprehensive compound profile with sourcing information, stacking synergies, and outcome timelines.